Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Some critical determinants of the behaviour of rats in the elevated plus-maze.

Griebel G, Moreau JL, Jenck F, Martin JR, Misslin R.

Behav Processes. 1993 Apr;29(1-2):37-47. doi: 10.1016/0376-6357(93)90026-N.

PMID:
24897695
2.

Tuberoinfundibular Peptide of 39 residues is required for germ cell development.

Usdin TB, Paciga M, Riordan T, Kuo J, Parmelee A, Petukova G, Camerini-Otero RD, Mezey E.

Endocrinology. 2008 Sep;149(9):4292-300. doi: 10.1210/en.2008-0419. Epub 2008 May 15.

3.

Involvement of septal Cdk5 in the emergence of excessive anxiety induced by stress.

Bignante EA, Rodriguez Manzanares PA, Mlewski EC, Bertotto ME, Bussolino DF, Paglini G, Molina VA.

Eur Neuropsychopharmacol. 2008 Aug;18(8):578-88. doi: 10.1016/j.euroneuro.2008.02.007. Epub 2008 Apr 10.

PMID:
18406108
4.

Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.

Mukhopadhyay P, Bátkai S, Rajesh M, Czifra N, Harvey-White J, Haskó G, Zsengeller Z, Gerard NP, Liaudet L, Kunos G, Pacher P.

J Am Coll Cardiol. 2007 Aug 7;50(6):528-36. Epub 2007 Jul 23.

5.

Acute effects of nicotine on restraint stress-induced anxiety-like behavior, c-Fos expression, and corticosterone release in mice.

Hsu HR, Chen TY, Chan MH, Chen HH.

Eur J Pharmacol. 2007 Jul 2;566(1-3):124-31. Epub 2007 Mar 30.

PMID:
17459372
6.
7.

Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice.

Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A.

J Neurosci. 2007 Jan 17;27(3):684-91.

8.
9.

Ethanol-related behaviors in serotonin transporter knockout mice.

Boyce-Rustay JM, Wiedholz LM, Millstein RA, Carroll J, Murphy DL, Daws LC, Holmes A.

Alcohol Clin Exp Res. 2006 Dec;30(12):1957-65.

PMID:
17117959
10.

Increased anxiety-like behavior during the post-stress period in mice exposed to repeated restraint stress.

Chotiwat C, Harris RB.

Horm Behav. 2006 Sep;50(3):489-95. Epub 2006 Jul 25.

PMID:
16870191
11.

Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease.

Karlsson RM, Holmes A.

Amino Acids. 2006 Oct;31(3):231-9. Epub 2006 May 29. Review.

PMID:
16733616
12.

Neuropeptides in psychiatric diseases: an overview with a particular focus on depression and anxiety disorders.

Belzung C, Yalcin I, Griebel G, Surget A, Leman S.

CNS Neurol Disord Drug Targets. 2006 Apr;5(2):135-45. Review.

PMID:
16611088
13.

The distribution and neurochemistry of the parathyroid hormone 2 receptor in the rat hypothalamus.

Dobolyi A, Irwin S, Wang J, Usdin TB.

Neurochem Res. 2006 Feb;31(2):227-36. Epub 2006 Mar 29.

PMID:
16570212
14.

Genetics of emotional regulation: the role of the serotonin transporter in neural function.

Hariri AR, Holmes A.

Trends Cogn Sci. 2006 Apr;10(4):182-91. Epub 2006 Mar 10. Review.

PMID:
16530463
15.

Afferent connections of the subparafascicular area in rat.

Wang J, Palkovits M, Usdin TB, Dobolyi A.

Neuroscience. 2006;138(1):197-220. Epub 2005 Dec 19.

PMID:
16361065
16.

The ascent of mouse: advances in modelling human depression and anxiety.

Cryan JF, Holmes A.

Nat Rev Drug Discov. 2005 Sep;4(9):775-90. Review.

PMID:
16138108
17.

Effect of different illumination levels on rat behavior in the elevated plus-maze.

Garcia AM, Cardenas FP, Morato S.

Physiol Behav. 2005 Jun 30;85(3):265-70.

PMID:
15927214
18.
19.

Unresolved questions about treatment-resistant anxiety disorders.

Stein DJ, Seedat S.

CNS Spectr. 2004 Oct;9(10):715. No abstract available.

PMID:
15448582
20.

Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior.

Holmes A, Li Q, Koenig EA, Gold E, Stephenson D, Yang RJ, Dreiling J, Sullivan T, Crawley JN.

Psychopharmacology (Berl). 2005 Mar;178(2-3):276-85. Epub 2004 Sep 10.

PMID:
15365683
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk